Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

• Novo Nordisk goes direct to consumer with Wegovy. What it means for obesity rival Eli Lilly

  Shares of Eli Lilly rose Wednesday despite its rival's announcement.
  
  CNBC - 10h
• 

  Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy

  Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight loss ...
  
  The Hill - 8h

• Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up

  The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
  
  MarketWatch - Feb. 26

• Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy

  The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.
  
  CNBC - 9h

• Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

  Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower doses in vials in August.
  
  CNBC - Feb. 25

• Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

  The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.
  
  CNBC - Feb. 21

• There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers

  Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.
  
  MarketWatch - 14h

• Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

  It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.
  
  CNBC - Feb. 26

• Novo Nordisk shares are rallying as Hims & Hers’ stock falters. An Ozempic alternative won’t be available for long.

  Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer.
  
  MarketWatch - Feb. 25

More from ABC News

• Trump administration moves to drop Idaho emergency abortion case with national implications

  The Trump administration is dropping an emergency abortion case in Idaho in one of the administration’s first moves on the issue since President Donald Trump's second term began
  
  ABC News - 11h
• 

  Judge orders nationwide block on Trump’s transgender youth health care policy

  A federal judge has extended a nationwide block on President Donald Trump’s executive orders halting federal funding for providers of gender-affirming health care for transgender people under age 19
  
  ABC News - 17h
• 

  World's oldest llama enjoys comforting chronically ill children in North Carolina

  A bucktoothed llama that spends his days comforting chronically ill children at a North Carolina camp founded by NASCAR royalty has been crowned the world’s oldest llama in captivity
  
  ABC News - 17h
• 

  Ultrasound now needed for pill abortions in Wyoming after lawmakers override veto

  Women planning pill abortions in Wyoming will need to get an ultrasound after lawmakers overrode the governor's veto of the new measure
  
  ABC News - 4h

• Georgia Senate advances bills to restrict gender-affirming care

  Senate Republicans in Georgia have advanced two bills restricting gender-affirming care for transgender people
  
  ABC News - 1d

More in Health

• 

  Ultrasound now needed for pill abortions in Wyoming after lawmakers override veto

  Women planning pill abortions in Wyoming will need to get an ultrasound after lawmakers overrode the governor's veto of the new measure
  
  ABC News - 4h
• 

  Women With Postpartum Depression Experienced Brain Changes During Pregnancy, Study Finds

  The research constitutes some of the first evidence that the condition is associated with modifications in the brain before childbirth.
  
  The New York Times - 7h
• 

  As Measles Spreads, Kennedy Embraces Remedies Like Cod Liver Oil

  In an interview, the H.H.S. secretary claimed that unconventional treatments were helping patients but described vaccination as a personal choice.
  
  The New York Times - 7h
• 

  Guarded N.I.H. Nominee Faces Sharp Questions on Vaccines and Research Cuts

  Dr. Jay Bhattacharya, a professor of medicine at Stanford University, gained prominence during the Covid pandemic when he argued against lockdowns.
  
  The New York Times - 7h

• Trump administration moves to drop Idaho emergency abortion case with national implications

  The Trump administration is dropping an emergency abortion case in Idaho in one of the administration’s first moves on the issue since President Donald Trump's second term began
  
  ABC News - 11h